Korean Journal of Pancreas and Biliary Tract最新文献

筛选
英文 中文
A Review on Clinical Outcomes of Pancreaticoduodenectomy in Octogenarian Patients 八十高龄患者胰十二指肠切除术的临床疗效综述
Korean Journal of Pancreas and Biliary Tract Pub Date : 2021-04-30 DOI: 10.15279/KPBA.2021.26.2.105
D. Coco, S. Leanza
{"title":"A Review on Clinical Outcomes of Pancreaticoduodenectomy in Octogenarian Patients","authors":"D. Coco, S. Leanza","doi":"10.15279/KPBA.2021.26.2.105","DOIUrl":"https://doi.org/10.15279/KPBA.2021.26.2.105","url":null,"abstract":"Management of malignant diseases in elderly patients has been a global clinical issue because of increased life expectancy worldwide. Currently, pancreatic adenocarcinoma mainly occurs after 60 years of age, and its prognosis remains poor despite modest improvements in recent decades. Surgical resection is the only potentially curative treatment for pancreatic cancer. Resection of the pancreas, either by pancreaticoduodenectomy (PD) or laparoscopic pancreaticoduodenectomy (LPD) is a complex surgical procedure with a high rate of morbidity and mortality. However, mortality rates after pancreatic surgery have dropped to less than 2-5% at experienced centers. Whereas, complication rates are high, reaching at least 30% in many centers. Mortality also increases proportionally with age viz. 6.7% of patients aged 65-69 years, 9.3% of patients aged 70-79 years, and 15.5% of patients aged 80 years or older. The present review article delineates clinical outcomes along with safety, morbidity and mortality after PD or LPD in elderly, especially in octogenarian patients.","PeriodicalId":229641,"journal":{"name":"Korean Journal of Pancreas and Biliary Tract","volume":"59 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127038428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Endoscopic Ultrasound-guided Radio-frequency Ablation for Pancreatic Cancer 超声内镜下射频消融治疗胰腺癌的研究
Korean Journal of Pancreas and Biliary Tract Pub Date : 2021-04-30 DOI: 10.15279/KPBA.2021.26.2.98
P. Kongkam, R. Rerknimitr
{"title":"Endoscopic Ultrasound-guided Radio-frequency Ablation for Pancreatic Cancer","authors":"P. Kongkam, R. Rerknimitr","doi":"10.15279/KPBA.2021.26.2.98","DOIUrl":"https://doi.org/10.15279/KPBA.2021.26.2.98","url":null,"abstract":"Prognosis of unresectable pancreatic cancer is poor with the rate of surviving more than 5 years is less than 10% despite multi-modalities treatment. The American Society of Clinical Oncology suggested that all patients with metastatic pancreatic cancer should be offered information about clinical trials. Endoscopic ultrasound guided radio frequency ablation has been recently used in patients with advanced stage pancreatic cancer in a few studies. This article has reviewed information from published articles using endoscopic ultrasound guided radio frequency ablation for advanced pancreatic cancer.","PeriodicalId":229641,"journal":{"name":"Korean Journal of Pancreas and Biliary Tract","volume":"26 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132220577","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Basic Knowledge that Doctors Starting ERCP Should Know 开始ERCP的医生应该知道的基本知识
Korean Journal of Pancreas and Biliary Tract Pub Date : 2021-04-30 DOI: 10.15279/KPBA.2021.26.2.89
Jung Wook Lee, H. Nam
{"title":"Basic Knowledge that Doctors Starting ERCP Should Know","authors":"Jung Wook Lee, H. Nam","doi":"10.15279/KPBA.2021.26.2.89","DOIUrl":"https://doi.org/10.15279/KPBA.2021.26.2.89","url":null,"abstract":"The first endoscopic retrograde cholangiopancreatography (ERCP) wad performed in 1968. With tremendous progress in techniques, instruments and devices, ERCP has played an important role in modern medicine for the diagnosis and management of various pancreaticobiliary diseases. ERCP has a potential risk of various complications even in the hands of the experts. The incidence of all ERCP-related complications is known to be about 4–10%, and that of fatal complications to be less than 0.5%. In order to prevent and minimize its side effects, the everyone who performs ERCP needs to fully understand various techniques and also recognize and deal with ERCP-related complications. In this review, we have summarized the must-know points in techniques and complications of ERCP for the beginners. Korean J Pancreas Biliary Tract 2021;26(2):89-97","PeriodicalId":229641,"journal":{"name":"Korean Journal of Pancreas and Biliary Tract","volume":"39 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127317482","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Recent Update of Accessories for ERCP 最近更新的ERCP附件
Korean Journal of Pancreas and Biliary Tract Pub Date : 2021-04-30 DOI: 10.15279/KPBA.2021.26.2.77
Tae Yoon Lee
{"title":"Recent Update of Accessories for ERCP","authors":"Tae Yoon Lee","doi":"10.15279/KPBA.2021.26.2.77","DOIUrl":"https://doi.org/10.15279/KPBA.2021.26.2.77","url":null,"abstract":"Endoscopic retrograde cholangiopancreatography (ERCP) became the standard method of choice for the management of patients with a variety of benign and malignant pancreaticobiliary disorders. A growing range of ERCP accessories has been developed to support the increasing demands and complexity of therapeutic ERCP. Various accessories are needed from selective cannulation to the removal of bile duct stones which involves endoscopic sphincterotomy or endoscopic papillary (large) balloon dilation with a balloon or basket-assisted stone extraction. Detailed knowledge and correct usage of accessories are essential to ensure optimal patient care and safety. This review describes current accessories that are available to use during diagnostic and therapeutic ERCP. Korean J Pancreas Biliary Tract 2021;26(2):77-84","PeriodicalId":229641,"journal":{"name":"Korean Journal of Pancreas and Biliary Tract","volume":"11 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126642497","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reporting Form of Endoscopic Retrograde Cholangiopancreatography: A National Survey in Korea 内窥镜逆行胆管造影报告表:韩国全国调查
Korean Journal of Pancreas and Biliary Tract Pub Date : 2021-04-30 DOI: 10.15279/KPBA.2021.26.2.120
H. Lee, S. Jang, Jae Min Lee, S. Shin, Y. Lee, H. Chon, J. Lee
{"title":"Reporting Form of Endoscopic Retrograde Cholangiopancreatography: A National Survey in Korea","authors":"H. Lee, S. Jang, Jae Min Lee, S. Shin, Y. Lee, H. Chon, J. Lee","doi":"10.15279/KPBA.2021.26.2.120","DOIUrl":"https://doi.org/10.15279/KPBA.2021.26.2.120","url":null,"abstract":"Reporting Form of Endoscopic Retrograde Cholangiopancreatography: A National Survey in Korea Hee Seung Lee, Sung Ill Jang, Jae Min Lee, Suk Pyo Shin, Yun Nah Lee, Hyung Ku Chon, Jun Kyu Lee, The Public Affair Board of Korean Pancreatobiliary Association Department of Internal Medicine, Yonsei University College of Medicine, Seoul; Department of Internal Medicine, Korea Universty College of Medicine, Seoul; Department of Internal Medicine, Hallym University College of Medicine, Chuncheon; Department of Internal Medicine, Soon Chun Hyang University School of Medicine, Bucheon; Department of Internal Medicine, Wonkwang University School of Medicine, Iksan; Department of Internal Medicine, Dongguk University College of Medicine, Goyang, Korea","PeriodicalId":229641,"journal":{"name":"Korean Journal of Pancreas and Biliary Tract","volume":"118 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123402553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Concurrent Diabetic Ketoacidosis and Acute Pancreatitis in Mild Hypertriglyceridemia: An Enigmatic Triangle 轻度高甘油三酯血症并发糖尿病酮症酸中毒和急性胰腺炎:一个神秘的三角形
Korean Journal of Pancreas and Biliary Tract Pub Date : 2021-04-30 DOI: 10.15279/KPBA.2021.26.2.111
Eunae Cho, C. Park
{"title":"Concurrent Diabetic Ketoacidosis and Acute Pancreatitis in Mild Hypertriglyceridemia: An Enigmatic Triangle","authors":"Eunae Cho, C. Park","doi":"10.15279/KPBA.2021.26.2.111","DOIUrl":"https://doi.org/10.15279/KPBA.2021.26.2.111","url":null,"abstract":"Hypertriglyceridemia (HTG) is a well-established cause of acute pancreatitis (AP). Diabetic ketoacidosis (DKA) leads to lipolysis and HTG, and can result in AP. Triad of AP, DKA, and HTG is rare and not fully understood. Usually AP is associated with severe HTG with serum triglyceride (TG) level over 1,000 mg/dL. However, we experienced two cases of AP in DKA with mild HTG with TG level less than 200 mg/dL. Herein, we report these unusual cases and provide a review of the literature about the triad of DKA, HTG, and AP. Korean J Pancreas Biliary Tract 2021;26(2):111-115","PeriodicalId":229641,"journal":{"name":"Korean Journal of Pancreas and Biliary Tract","volume":"45 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"120996869","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Knowledge of Insurance Claim for ERCP Beginner 初级ERCP保险理赔知识
Korean Journal of Pancreas and Biliary Tract Pub Date : 2021-04-30 DOI: 10.15279/KPBA.2021.26.2.85
K. Lee
{"title":"Knowledge of Insurance Claim for ERCP Beginner","authors":"K. Lee","doi":"10.15279/KPBA.2021.26.2.85","DOIUrl":"https://doi.org/10.15279/KPBA.2021.26.2.85","url":null,"abstract":"In performing endoscopic retrograde cholangiopancreatography (ERCP), doctors should know the details of insurance claims. The fee of ERCP will be charged separately by the treatment fee and the material costs, and should be charged according to the insurance claims to avoid any disadvantages later. Insurance claims for ERCP are often changed, so doctors have to notice the changes and apply them. During the procedure, it is important to properly record the photograph as a basis, and to keep a good description of the procedure and materials used on the reading sheet. After the procedure, it is necessary to double check the prescription and verify that the insurance claim has been properly filed.","PeriodicalId":229641,"journal":{"name":"Korean Journal of Pancreas and Biliary Tract","volume":"26 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133064984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effect of Fluoroscopy Control on Cannulation Rate and Fluoroscopy Time in Endoscopic Retrograde Cholangiopancreatography Training 内镜逆行胆管造影训练中透视控制对插管率和透视时间的影响
Korean Journal of Pancreas and Biliary Tract Pub Date : 2021-01-31 DOI: 10.15279/KPBA.2021.26.1.43
Raymond E. Kim, L. Uradomo, Grace E. Kim, John D. Morris, E. Goldberg, P. Darwin
{"title":"The Effect of Fluoroscopy Control on Cannulation Rate and Fluoroscopy Time in Endoscopic Retrograde Cholangiopancreatography Training","authors":"Raymond E. Kim, L. Uradomo, Grace E. Kim, John D. Morris, E. Goldberg, P. Darwin","doi":"10.15279/KPBA.2021.26.1.43","DOIUrl":"https://doi.org/10.15279/KPBA.2021.26.1.43","url":null,"abstract":"43 Copyright © 2021 by Korean Pancreatobiliary Association The Effect of Fluoroscopy Control on Cannulation Rate and Fluoroscopy Time in Endoscopic Retrograde Cholangiopancreatography Training Raymond E. Kim, Lance T. Uradomo, Grace E. Kim, John D. Morris, Eric M. Goldberg, Peter E. Darwin Division of Gastroenterology and Hepatology, University of Maryland School of Medicine, Baltimore, MD; Department of Internal Medicine, University of Maryland Medical Center, Baltimore, MD, USA","PeriodicalId":229641,"journal":{"name":"Korean Journal of Pancreas and Biliary Tract","volume":"6 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129499484","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intrahepatic Cholangiocarcinoma: Evolving Concepts and Medical Treatment 肝内胆管癌:不断发展的概念和医学治疗
Korean Journal of Pancreas and Biliary Tract Pub Date : 2021-01-31 DOI: 10.15279/KPBA.2021.26.1.33
Hong-Ja Kim
{"title":"Intrahepatic Cholangiocarcinoma: Evolving Concepts and Medical Treatment","authors":"Hong-Ja Kim","doi":"10.15279/KPBA.2021.26.1.33","DOIUrl":"https://doi.org/10.15279/KPBA.2021.26.1.33","url":null,"abstract":"Cholangiocarcinoma (bile duct cancer) is classified into intrahepatic and extrahepatic cholangiocarcinoma (perihilar and distal cholangiocarcinoma) according to the anatomical location of the lesion. The incidence of extrahepatic cholangiocarcinoma has been relatively stagnant in recent decades, but intrahepatic cholangiocarcinoma is steadily increasing worldwide, requiring attention. Various classification systems based on gross growth patterns, histological findings, and tumor-derived cells, as well as classification based on existing anatomical location, have been proposed, however, the consensus has not been established yet. Intrahepatic cholangiocarcinoma is a carcinoma with an extremely poor prognosis. Complete tumor resection is the only curative treatment. The overall survival rate for 5 years after surgery is 15% to 40%, but recurrence after surgery is observed in 2/3 patients. Therefore, determining the right stage before surgery and selecting an appropriate treatment method through a multidisciplinary approach is a very important process in determining proper treatment. Systemic therapy may be used for locally advanced biliary tract cancer or metastatic biliary tract cancer where surgery is not possible. However, the effectiveness of traditional anticancer chemotherapeutic agents is rather pessimistic, therefore treatments using molecular biological properties have recently been attempted. Finding a way to increase the number of resectable cases through early diagnosis is one of the main challenges. In addition, it is also hoped that the selection of new therapeutic targets and therapeutics will be possible as a result of advanced research on gene expression profiles and mutations in cholangiocarcinoma.","PeriodicalId":229641,"journal":{"name":"Korean Journal of Pancreas and Biliary Tract","volume":"55 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129082788","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current Paradigm of Treatment for Pancreatic Neuroendocrine Tumor 胰腺神经内分泌肿瘤的当前治疗模式
Korean Journal of Pancreas and Biliary Tract Pub Date : 2021-01-31 DOI: 10.15279/KPBA.2021.26.1.24
M. Sung, M. Chung
{"title":"Current Paradigm of Treatment for Pancreatic Neuroendocrine Tumor","authors":"M. Sung, M. Chung","doi":"10.15279/KPBA.2021.26.1.24","DOIUrl":"https://doi.org/10.15279/KPBA.2021.26.1.24","url":null,"abstract":"Pancreatic neuroendocrine tumor (PNET) refer to tumors originating from the islet of Langerhans and shows various prognosis based on the presence or absence of symptoms due to hormone secretion, the Ki-67 cell proliferation index, and the histologic grade, and according to the degree of disease progression defined by the tumor-node-metastasis (TNM) stage classification. The purpose of medical treatment for PNET is to control symptoms or inhibit tumor growth. Somatostatin analogues can be administered for the purpose of controlling symptoms caused by the secretion of specific hormones, and are accepted as effective drugs for inhibiting the progression of G1/G2 tumors based on World Health Organization (WHO) classification with a Ki67 cell proliferation index less than 20%. Among the molecularly targeted agents, everolimus and sunitinib can be considered in patients with WHO G1/G2 PNET showing progression after somatostatin analog therapy. Cytotoxic chemotherapy is generally administered to patients with large tumor volume and rapidly progressing metastatic NET, and etoposide/cisplatin combination therapy has been considered as a standard treatment. For the patient group of Grade 3 PNET (well differentiated) newly classified by the WHO 2017 classification, guidelines for standard treatment have not yet been established. As it has been reported, studies are needed to evaluate the treatment response rate of somatostatin analogues or molecularly targeted therapies for the patient with Grade 3 PNET. It is important to consider a multidisciplinary approach with all possible treatment options including medical treatment, radical resection of primary or metastatic lesions, liver-directed therapies, and peptide receptor radionuclide therapy for the patients with PNET.","PeriodicalId":229641,"journal":{"name":"Korean Journal of Pancreas and Biliary Tract","volume":"41 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130489737","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书